100% satisfaction
Premium peptides
Checkout
| Test Item | Specification | Result | Status |
|---|---|---|---|
| Appearance | White lyophilized powder | White powder | Pass |
| Identification (HPLC) | RT matches std | RT = 12.34 min | Pass |
| pH (1% solution) | 6.0 - 7.0 | 6.5 | Pass |
| Water Content (KF) | NMT 3.0% | 1.5% | Pass |
| Peptide Content | NLT 95.0% | 98.1% | Pass |
| Purity (HPLC) | NLT 98.0% | 99.7% | Pass |
| Endotoxin (LAL) | NMT 5 EU/mg | < 0.3 EU/mg | Pass |
| Assay (Content) | 95.0 - 105.0% | 99.8% | Pass |
| GIP/GLP-1 Activity | Dual agonist confirmed | Pass | Pass |
| Sterility | Sterile | Sterile | Pass |
Synedica Tirzepatide Injection Pen Kit is the world's most advanced weight loss solution. Tirzepatide is an advanced medication which suppresses appetite leading to significant weight loss. It does this by mimicking the effects of the GLP-1 and GIP receptors, which are natural hormones that makes humans feel full from eating much smaller portions of food.
The Synedica Tirzepatide 40mg Injection Pen Kit contains 1 pen, 12 disposable needles and an instruction booklet. Each pen has 40mg which can be delivered across 4 full doses of 10mg, or in increments of 2.5mg, 5mg, 7.5mg or 10mg. Recommended dosage is 2.5mg for the first 4 weeks, then 5mg for the next 4 weeks. After 8 weeks the weekly dosage may be increased to 7.5mg or 10mg if necessary.
Thermal, enzymatic, and oxidative degradation studies. Shelf-life evaluation & formulation robustness.
Enhances solubility, bioavailability, and structural integrity. Tailored for injectable, topical, and research-grade use.
Evaluates interactions between peptides & inactive components. Ensures safety, stability, and performance.
Assesses susceptibility to enzymatic breakdown. Supports development of more durable peptide products.
Liposomes, microspheres, and other delivery vehicles. Protects peptides & enables controlled release.
Optimized for parenteral delivery (injectables), dermal absorption (cosmetic/topical), and in vitro research applications.
